open access

Vol 9, No 4 (2020)
ORIGINAL ARTICLES
Published online: 2020-07-06
Get Citation

C/T polymorphism of the rs7903146 nucleotide of the TCF7L2 gene and the risk of developing diabetes mellitus type 2

Ryszard Swoboda, Maciej Molsa, Marek Tłuczykont, Anna Markowicz, Marta Biedak, Anna Kałuża, Sebastian Sirek, Władysław Grzeszczak, Krzysztof Strojek
DOI: 10.5603/DK.2020.0022
·
Clinical Diabetology 2020;9(4):212-218.

open access

Vol 9, No 4 (2020)
ORIGINAL ARTICLES
Published online: 2020-07-06

Abstract

Background. The continuously increasing incidence of type 2 diabetes mellitus (DMt2) is an important prob­lem in current medicine. In addition to well-known environmental factors that may contribute to this disease, genetic factors may also play a role. One of the genes that may be responsible for an increased risk of DMt2 development is the transcription factor TCF7L2 gene. This work was aimed to assess a correlation between the rs7903146 polymorphism in the TCF7L2 gene and age at DMt2 diagnosis, presence of obesity, arterial hypertension, and time elapsed from DMt2 diagnosis to the start of insulin therapy.

Methods. An analysis of the studied polymorphism was performed in 282 patients diagnosed with DMt2. Patients were divided into groups depending on the age of the onset of DMt2: group A (n = 82) — DMt2 diagnosis below the age of 40 years, group B (n = 100) — DMt2 diagnosis between the ages of 40 and 60 years, group C (n = 100) — DMt2 diagnosis above the age of 60 years.

Results. In group C, there was a significantly lower number of patients with a TT genotype of the studied polymorphism compared to the combined group A + B (P < 0.05).

Conclusions. There is a correlation between the rs7903146 polymorphism in the TCF7L2 gene and age at DMt2 diagnosis. No correlation has been demonstrated between the studied polymorphism and the presence of obesity, arterial hypertension, and time elapsed from DMt2 diagnosis to the start of insulin therapy.

Abstract

Background. The continuously increasing incidence of type 2 diabetes mellitus (DMt2) is an important prob­lem in current medicine. In addition to well-known environmental factors that may contribute to this disease, genetic factors may also play a role. One of the genes that may be responsible for an increased risk of DMt2 development is the transcription factor TCF7L2 gene. This work was aimed to assess a correlation between the rs7903146 polymorphism in the TCF7L2 gene and age at DMt2 diagnosis, presence of obesity, arterial hypertension, and time elapsed from DMt2 diagnosis to the start of insulin therapy.

Methods. An analysis of the studied polymorphism was performed in 282 patients diagnosed with DMt2. Patients were divided into groups depending on the age of the onset of DMt2: group A (n = 82) — DMt2 diagnosis below the age of 40 years, group B (n = 100) — DMt2 diagnosis between the ages of 40 and 60 years, group C (n = 100) — DMt2 diagnosis above the age of 60 years.

Results. In group C, there was a significantly lower number of patients with a TT genotype of the studied polymorphism compared to the combined group A + B (P < 0.05).

Conclusions. There is a correlation between the rs7903146 polymorphism in the TCF7L2 gene and age at DMt2 diagnosis. No correlation has been demonstrated between the studied polymorphism and the presence of obesity, arterial hypertension, and time elapsed from DMt2 diagnosis to the start of insulin therapy.

Get Citation

Keywords

diabetes type 2, TCF7L2 gene, age, polymorphism

About this article
Title

C/T polymorphism of the rs7903146 nucleotide of the TCF7L2 gene and the risk of developing diabetes mellitus type 2

Journal

Clinical Diabetology

Issue

Vol 9, No 4 (2020)

Pages

212-218

Published online

2020-07-06

DOI

10.5603/DK.2020.0022

Bibliographic record

Clinical Diabetology 2020;9(4):212-218.

Keywords

diabetes type 2
TCF7L2 gene
age
polymorphism

Authors

Ryszard Swoboda
Maciej Molsa
Marek Tłuczykont
Anna Markowicz
Marta Biedak
Anna Kałuża
Sebastian Sirek
Władysław Grzeszczak
Krzysztof Strojek

References (30)
  1. Polakowska M, Piotrowski W. Incidence of diabetes in the Polish population: results of the Multicenter Polish Population Health Status Study--WOBASZ. Pol Arch Med Wewn. 2011; 121(5): 156–163.
  2. Morris AP, Voight BF, Teslovich TM, et al. Wellcome Trust Case Control Consortium, Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) Investigators, Genetic Investigation of ANthropometric Traits (GIANT) Consortium, Asian Genetic Epidemiology Network–Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44(9): 981–990.
  3. Grant SFA, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006; 38(3): 320–323.
  4. Sale MM, Smith SG, Mychaleckyj JC, et al. Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes. 2007; 56(10): 2638–2642.
  5. Scott LJ, Bonnycastle LL, Willer CJ, et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes. 2006; 55(9): 2649–2653.
  6. Miyake K, Horikawa Y, Hara K, et al. Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects. J Hum Genet. 2008; 53(2): 174–180.
  7. Chang YC, Chang TJ, Jiang YD, et al. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes. 2007; 56(10): 2631–2637.
  8. Turki A, Al-Zaben GS, Mtiraoui N, et al. Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Tunisian Arab subjects. Gene. 2013; 513(2): 244–248.
  9. Nemr R, Turki A, Echtay A, et al. Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Lebanese subjects. Diabetes Res Clin Pract. 2012; 98(3): e23–e27.
  10. Peng S, Zhu Y, Lü B, et al. TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121,174 subjects. Mutagenesis. 2013; 28(1): 25–37.
  11. Ip W, Chiang YTA, Jin T. The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: The current understanding, dispute, and perspective. Cell Biosci. 2012; 2(1): 28.
  12. Lukacs K, Hosszufalusi N, Dinya E, et al. The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia. 2012; 55(3): 689–693.
  13. Cauchi S, Vaxillaire M, Choquet H, et al. No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects. Diabetologia. 2007; 50(1): 214–216.
  14. Andersen MK, Sterner M, Forsén T, et al. Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes. Diabetologia. 2014; 57(9): 1859–1868.
  15. Pagán A, Sabater-Molina M, Olza J, et al. A gene variant in the transcription factor 7-like 2 (TCF7L2) is associated with an increased risk of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol. 2014; 180: 77–82.
  16. Klein K, Haslinger P, Bancher-Todesca D, et al. Transcription factor 7-like 2 gene polymorphisms and gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2012; 25(9): 1783–1786.
  17. Florez JC, Jablonski KA, Bayley N, et al. Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006; 355(3): 241–250.
  18. Saxena R, Gianniny L, Burtt NP, et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes. 2006; 55(10): 2890–2895.
  19. Zhang C, Qi Lu, Hunter DJ, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. Diabetes. 2006; 55(9): 2645–2648.
  20. Loos RJF, Franks PW, Francis RW, et al. TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes. 2007; 56(7): 1943–1947.
  21. González-Sánchez JL, Martínez-Larrad MT, Zabena C, et al. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population. Diabetologia. 2008; 51(11): 1993–1997.
  22. Gustafson B, Smith U. WNT signalling is both an inducer and effector of glucagon-like peptide-1. Diabetologia. 2008; 51(10): 1768–1770.
  23. National Center for Biotechnology Information: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=7903146.
  24. Kim KS, Oh HJ, Kim JW, et al. The clinical characteristics of the newly diagnosed early onset (< 40 years old) diabetes in outpatients' clinic. Korean Diabetes J. 2010; 34(2): 119–125.
  25. Hillier TA, Pedula KL. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care. 2003; 26(11): 2999–3005.
  26. Lehman DM, Hunt KJ, Leach RJ, et al. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes. 2007; 56(2): 389–393.
  27. Silbernagel G, Renner W, Grammer TB, et al. Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon-like peptide 1. Diabetes Metab Res Rev. 2011; 27(5): 499–505.
  28. Bartman W, Nabrdalik K, Kwiendacz H, et al. Association between carotid plaque score and microvascular complications of type 2 diabetes. Pol Arch Intern Med. 2017; 127(6): 418–422.
  29. Kahveci C, Koldemir M, Cagatay P, et al. Relationship of transcription factor 7 like 2 gene rs7903146 variation with type 2 diabetes and obesity related parameters. Diabetes Metab Syndr. 2012; 6(1): 48–53.
  30. Bielinski SJ, Pankow JS, Folsom AR, et al. TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia. 2008; 51(6): 968–970.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl